Navigation Links
Creation of Cytomegalovirus Vaccine by an Innovative Method

Human cytomegalovirus, or CMV infects about 40,000 children before birth and about 8,000 of these children suffer permanent disabilities due to the virus – almost one an hour.//

Such disabilities can include vision loss, hearing loss, mental disability, a lack of coordination, and seizures. According to the Centers for Disease Control and Prevention, CMV is as common a cause of serious disability as Down syndrome, fetal alcohol syndrome, or neural tube defects.

Because of the dangers posed by the virus to infants, the Institute of Medicine has declared that development of a CMV vaccine should be one of the highest priorities for vaccine makers. Now, in a new study in the August 1 issue of The Journal of Virology, researchers at The Wistar Institute outline an innovative approach that could be used to create such a vaccine.

The Wistar scientists began with the observation that mice harbor a species-specific form of CMV that is unable to sustain an infection in humans and is completely harmless to them. They then asked whether, using recombinant technologies, there might not be a way to shift the mouse-specific virus closer to the human-specific virus to generate a version of the virus able to elicit a protective immune response but not a dangerous infection in humans.

With this goal, the researchers began to systematically introduce selected genes from human CMV into the genome of mouse CMV in the laboratory. The result was a novel form of CMV virus that infected human cells well enough that it might trigger an immune response but not well enough to sustain an infection.

"It should be possible to develop a safe and effective CMV vaccine using the method we've described in our study," says Gerd G. Maul, Ph.D., a professor in the Gene Expression and Regulation Program at Wistar and senior author on the new study. "Success will depend on achieving a certain balance between the immune-stimulating genes from the
'"/>




Page: 1 2

Related medicine news :

1. FDA Approves Novel Creation of Imitrex? Injection for Migraine
2. OBC Stir Media Creation: Ramadoss
3. Anti-quota Stir is a Creation of the Media: Ramadoss
4. Innovative Method for Creating a Human Cytomegalovirus Vaccine Outlined
5. Vaccine to quit smoking?
6. First Vaccine Designed for Africa Cleared for Testing in Humans
7. Vaccine for Alzheimer’s diseas
8. Health Officials Recommend Flu Vaccine
9. Smallpox Vaccine May Help Fight Cervical Cancer
10. Panacea Biotech To Market Anthrax Vaccine
11. New Prostate Cancer Vaccine Shows Promise
Post Your Comments:
(Date:10/15/2008)... Will Educate Parents about Prescription,Drug Abus...mily Partnership (NFP),has designated Monday, Octo...g off the group,s 23rd annual Red Ribbon Week from...ents with action steps to prevent children,s,presc...million teens in the United States abuse,prescript...
(Date:10/14/2008)...4 /PRNewswire-USNewswire/ -- Kerby T.,Alvy, Ph.D.,...r for the,Improvement in North Hollywood (CICC), h... and Prevention (CDC) to serve as an expert to inf...or the prevention of child,maltreatment., CDC,s n...lationships,(SSNR) as the foundation for a unified...
(Date:10/14/2008)...ker Founder and CEO Andrew Levitt to showcase Heal... Somerville, MA (PRWEB) Octob... , the word-of-mouth marketing (WOM) firm for the ... announced that Andrew Levitt, Founder and CEO of ...Pharma and Health 2.0" at Health 2.0: User-Ge...
(Date:10/14/2008)...PRNewswire-FirstCall/ -- Warner Chilcott,Limited (... its third quarter,2008 financial results prior to... In addition to issuing a press release, the Comp... parties on Monday, November 10, 2008 at,8:00 AM (...e in the call,please dial (877) 856-1955 in the U...
Breaking Medicine News(10 mins):Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 2Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 3Health News:Los Angeles Psychologist to Help CDC Fight Child Abuse 2Health News:HealthTalker Founder and CEO Andrew Levitt to be Featured at 'Health 2.0: User-Generated Healthcare 2008' 2
...as A&M University said that poorly maintained whir...reeding grounds for potentially lethal bacterial s... of them had some kind of microbial growth.// Var...found in feces contributed about 95% of the sample...
...that women in India are gradually becoming more su...bout 40 percent of India’s infected population//. ...nfection. Besides, gender disparities, lack of edu...king the situation worse," said Archana Tamang, ch...
...r a long time that mutual antagonism between husba...sease//. It has now been possible to pinpoint the ...al disagreements can lead to hardening of coronary...lling behavior of either spouse has been found to ...
...ut out for junk foods in schools from September on...cording to the recommendations// by the School Foo...elly, education secretary, has enforced new standa... – that includes vending machines, tuck shops and ...
Other Medicine News:Health News:Biologically Women Are More Vulnerable To HIV Infection 2Health News:Heart disease: Men Are From Mars, Women From Venus 2
(Date:10/14/2008)...4 /PRNewswire-USNewswire/ -- Susan G. Komen for th...n unprecedented $100,million in grants to American...ast track breast cancer research. Grants were also... from the Barbara Ann Karmanos Cancer Institute an... Boerner, Ph.D., assistant,professor, and Guojun W...
(Date:10/14/2008)...t. 10 /- Regado Biosciences, Inc.,an... in the Phase IIa,clinical study of its REG1 Antic...percutaneous coronary intervention (PCI). REG1 is ...d anticoagulant, RB006, and its matched,active re...nd neutralizes,RB006. The Phase IIa study (REVERSA...
(Date:10/13/2008)... million dollar NIH funding advances study S... rates, MINNEAPOLIS, Oct. 13 /- Adva...edcirculatory.com ) announced today that it has re...the National Institutes of,Health (NIH) to continu...on,those who experience cardiac arrest outside a h...
(Date:10/13/2008)...nnounce Interim Results in January 2009 and Final ..., EMERYVILLE, Calif., Oct. 13 /PRNewswire-FirstCa... (Nasdaq: NTII ) today announced that following a...n to discuss the,Viprinex(TM) (ancrod) Phase 3 cli...ny plans to consolidate and analyze data from its ...
Breaking Medicine Technology:Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 2Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 3Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 4Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 5Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System 2Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System 3Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques 2Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 2Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 3Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 4Before Every Surgery Take a TIME OUT 28R 29 5745 1Before Every Surgery Take a TIME OUT 28R 29 5745 2Black Athletes Hearts May Differ From Those of Whites 20899 1Black Athletes Hearts May Differ From Those of Whites 20899 2Black Athletes Hearts May Differ From Those of Whites 20899 3Katzen Eye Group Announces a New Option in Vision Correction Technology for Patients 20895 1Katzen Eye Group Announces a New Option in Vision Correction Technology for Patients 20895 2Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 1Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 2Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 3Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 4
...ated for the treatment of plantar fasciitis and Ac...ply. The splint features adjustable dorsiflexion a... nightly contractures and tightening of the planta... flexibility in the treatment of the problem by al...
Comfortably positions the affected foot at 90 to provide continuous and effective stretching of the plantar fascia and Achilles Tendon
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
... compression and cold, the Foot Cryo/Cuff minimize...ly designed cuff provides complete foot coverage f...ed as a single cuff, or with a cooler (including a... available separately and can be used with any mod...
Medicine Products: